Search research articles
Contact Us
Filters
Showing results (141-150 of 584) with videos related to
Page
of 59
Sort By:
Psychosomatic Medicine
|
March 8, 2000
Anxiety, depression, and heart rate variability
R M Carney, K E Freedland, P K Stein
The American Journal of Medicine
|
January 1, 1997
How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?
Y I Sheline, K E Freedland, R M Carney
Life Sciences
|
March 11, 1985
Discriminative stimulus properties of methylxanthines and their metabolites in rats
J M Carney, F A Holloway, H E Modrow
Comprehensive Therapy
|
November 1, 1989
Psychiatric depression, anxiety, and coronary heart disease
R M Carney, M W Rich, K E Freedland
Annals of the American Thoracic Society
|
February 21, 2015
Immunostaining in lung cancer for the clinician. Commonly used markers for differentiating primary and metastatic pulmonary tumors
John M Carney, Alyssa M Kraynie, Victor L Roggli
Journal of the American College of Cardiology
|
July 24, 2024
Treating Depression to Improve Survival in Coronary Heart Disease: What Have We Learned?
Robert M Carney, Kenneth E Freedland, Michael W Rich
Acta Neurochirurgica. Supplementum
|
January 1, 1990
Inducible ornithine decarboxylase expression in brain subject to vasogenic oedema after transient ischaemia: relationship to C-fos gene expression
R J Dempsey, J M Carney, M S Kindy
Medical Hypotheses
|
January 20, 2004
The role of psychosocial factors in the progression of hepatocellular carcinoma
J Steel, M Carney, B I Carr, et al.
International Journal of Behavioral Medicine
|
March 4, 2005
Effects of anxiety and depression on heart disease attributions
Ryan C Day, Kenneth E Freedland, Robert M Carney
Psychosomatic Medicine
|
November 27, 2004
Depression is a risk factor for mortality in coronary heart disease
Robert M Carney, Kenneth E Freedland, David S Sheps
Page
of 59
Search research articles
Search
Showing results (141-150 of 584) with videos related to
Sort By:
Page
of 59
Psychosomatic Medicine
|
March 8, 2000
Anxiety, depression, and heart rate variability
R M Carney, K E Freedland, P K Stein
The American Journal of Medicine
|
January 1, 1997
How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?
Y I Sheline, K E Freedland, R M Carney
Life Sciences
|
March 11, 1985
Discriminative stimulus properties of methylxanthines and their metabolites in rats
J M Carney, F A Holloway, H E Modrow
Comprehensive Therapy
|
November 1, 1989
Psychiatric depression, anxiety, and coronary heart disease
R M Carney, M W Rich, K E Freedland
Annals of the American Thoracic Society
|
February 21, 2015
Immunostaining in lung cancer for the clinician. Commonly used markers for differentiating primary and metastatic pulmonary tumors
John M Carney, Alyssa M Kraynie, Victor L Roggli
Journal of the American College of Cardiology
|
July 24, 2024
Treating Depression to Improve Survival in Coronary Heart Disease: What Have We Learned?
Robert M Carney, Kenneth E Freedland, Michael W Rich
Acta Neurochirurgica. Supplementum
|
January 1, 1990
Inducible ornithine decarboxylase expression in brain subject to vasogenic oedema after transient ischaemia: relationship to C-fos gene expression
R J Dempsey, J M Carney, M S Kindy
Medical Hypotheses
|
January 20, 2004
The role of psychosocial factors in the progression of hepatocellular carcinoma
J Steel, M Carney, B I Carr, et al.
International Journal of Behavioral Medicine
|
March 4, 2005
Effects of anxiety and depression on heart disease attributions
Ryan C Day, Kenneth E Freedland, Robert M Carney
Psychosomatic Medicine
|
November 27, 2004
Depression is a risk factor for mortality in coronary heart disease
Robert M Carney, Kenneth E Freedland, David S Sheps
Page
of 59